The U.S. District Judge presiding over all federal Bard hernia mesh lawsuits has issued a limited stay on the active litigation, pausing all discovery and pretrial proceedings, as the parties close in on a potential global settlement agreement to resolve claims brought by individuals nationwide.

C.R. Bard currently faces more than 21,000 separate product liability lawsuits, each involving similar allegations that users suffered painful and debilitating injuries caused by design defects associated with various polypropylene products sold in recent years, including the Bard Ventralight, Bard Ventralex, Bard Perfix Plug, Bard 3D Max, and similar systems.

Since August 2018, the hernia mesh lawsuits have been centralized before U.S. District Judge Edmund A. Sargus in the Southern District of Ohio, as part of a federal Bard hernia mesh multidistrict litigation, or MDL.

Following mixed results in three early bellwether test trials, which were held to help determine how juries may respond to certain evidence and testimony that may be repeated throughout the claims, Judge Sargus ordered the parties to meet with a mediator over the past three months, to conduct intensive Bard hernia mesh settlement talks before he considers returning large numbers of claims to various different U.S. District Courts nationwide for trial.

However, based on a series of case management orders issued over the weekend, including docket control measures that impose strict deadlines on any new claims that may be filed in the future, it appears that an agreement on settling Bard hernia mesh claims may soon be announced by the parties.